key: cord-0689720-fkld8fsf
authors: Xia, Guozhi; Fan, Di; Ma, Chaoran; He, Yanru; Wang, Ming; Zhu, Yaowu; Zheng, Qiangsun
title: Hyper-Inflammatory Response Involves in Cardiac Injury among Patients with Coronavirus Disease 2019
date: 2021-02-12
journal: Am J Med Sci
DOI: 10.1016/j.amjms.2021.02.007
sha: c9504e004c717df47a3480fab462f5921ec278ec
doc_id: 689720
cord_uid: fkld8fsf

BACKGROUND: Coronavirus disease 2019 (COVID-19) is still ongoing throughout the world and has resulted in considerable fatality. Inflammation and cardiac injury are commonly observed in these cases. However, the association between the hyper-inflammatory response and cardiac injury among patients with COVID-19 remains unknown. METHODS: The study was designed based on severe and critically ill patients with COVID-19. Information on demographics and baseline clinical characteristics as well as laboratory examinations were collected from the electronic medical records and analyzed. RESULTS: There were 32.4% (n = 107) of patients presenting with cardiac injury. The median age was 67 years, and 48.8% (n = 161) of patients were men. Hypertension was the most common in 161 (48.8%) patients, followed by diabetes (16.7%, n = 55) and coronary heart disease (13.3%, n = 44). Moreover, compared to cases without cardiac injury, those with cardiac injury were older, had higher proportions of coronary heart disease, had significantly elevated leukocyte counts and concentrations of N-terminal pro-B-Type natriuretic peptide, high-sensitivity C-reactive protein (hs-CRP), tumor necrosis factor (TNF)-α, interleukin-2 receptor (IL-2R), IL-6, and IL-8, but lower lymphocyte counts. A significant positive correlation was observed between high-sensitivity troponin I and hs-CRP, TNF-α, IL-2R, IL-6 and IL-8. Stepwise logistic regression analysis showed that hs-CRP, TNF-α and IL-6 were independent risk factors for cardiac injury. CONCLUSIONS: Pro-inflammatory cytokines were associated with cardiac injury among severe and critically ill patients with COVID-19, suggesting that hyper-inflammatory response may involve in cardiac injury.

Coronavirus disease 2019 (COVID- 19) , a new type of highly contagious illness in human, has caused an emerging serious outbreak. The causative agent of COVID-19 is a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is an enveloped, single-stranded, positive-sense RNA virus, producing a respiratory and systemic illness and progressing to a severe pneumonia. 1 According to updated statistics reported by the World Health Organization (WHO), COVID-19 has already affected over 3 900 000 people throughout the world, carrying a fatality of approximately 6.9% by May 8, 2020 . It has been reported that cardiac injury was commonly observed in severe and critically ill cases and associated with fatality. 2, 3 Cytokines have been thought to play a pivotal role in regulating inflammatory response during virus infections. 4, 5 Accumulating evidences have shown that increased amounts of inflammatory cytokines in serum are related to pulmonary inflammatory response in COVID-19. 2, 3, 6 To our knowledge, no studies have been done among patients with COVID-19 on the correlation between inflammatory cytokines and cardiac injury. Therefore, the present study retrospectively analyzed the data from a single center in Wuhan, China, to elucidate the potential association between pro-inflammatory cytokines and cardiac injury for guiding therapies and reducing fatality of severe and critically ill patients with COVID-19. 4 

This single-center, retrospective, observational study was designed based on severe and critically ill patients with COVID-19 admitted to hospitalization at Tongji Hospital of Huazhong University of Science and Technology, located in Wuhan, China. The hospital was assigned responsibility for treatment of patients with severe and critically ill COVID-19 by the Wuhan government from February 1, 2020, to March 10, 2020. All patients were tested positive for SARS-CoV-2 by use of real-time reverse-transcriptase polymerase-chain reaction (RT-PCR) on throat swab specimens. The severe and critically illness of COVID-19 was identified according to the Seventh Revised Trial Version of the Novel Coronavirus Pneumonia Diagnosis and Treatment Guidance published by the National Health Commission of China. 7 Those who met following criteria were defined as severe illness: (1) Respiratory distress with respiratory rate over 30 times per minute; (2) Oxygen saturation ≤ 93% in the resting state; (3) Arterial blood oxygen partial pressure / fraction of inspired oxygen ≤ 300 mm Hg. Critically ill patients were defined as those admitted to the hospital who had either one of the following criteria: (1) Respiratory failure in need of mechanical ventilation; (2) Shock; (3) Other organ dysfunction.

Patients were excluded when they had hospitalization length-of stay of < 24 hours; lacked medical records; were not laboratory-confirmed up to March 24, 2020; had history of renal insufficiency; lacked a serum high-sensitivity troponin I (hs-cTnI ) measurement. A total of 330 patients aged > 42 years enrolled in our study were categorized into the cardiac injury group and the non-cardiac injury group. Cardiac injury was defined as the serum level of hs-cTnI above the 99th percentile upper reference limit (26.2 pg/mL). 2 The study was conducted in accordance with the principles of the declaration of the National

Hospital of Huazhong University of Science and Technology (Approval number WDRY2020-K061) and written informed consent was waived by the Ethics Commission of the designated hospital for patients due to the rapid emergence of this infectious disease.

Data from the electronic medical records were obtained from February 1, 2020, to March 10, 2020. We collected information on demographics and baseline clinical characteristics including 5 age, gender, current smoker, heart rate, systolic blood pressure (SBp), diastolic blood pressure (DBp), cardiovascular comorbidities. We also collected chest computed χ-ray tomography (CT) images and the laboratory data on hs-cTnI, N-terminal pro-B-Type natriuretic peptide (NT-proBNP), routine blood examinations including leukocyte counts, lymphocyte counts, haemoglobin, albumin, alanine aminotransferase (ALT), aspartate aminotransferas (AST), urea nitrogen, serum creatinine and inflammatory cytokines including high-sensitivity C-reactive protein (hs-CRP), tumor necrosis factor (TNF)-α, interleukin-2 receptor (IL-2R), IL-1β, IL-6, IL-8, IL-10 on admission.

Throat swab specimens were extracted and tested for SARS-CoV-2 by real-time RT-PCR. The 

Continuous data were presented as median with interquartile range (IQR), and categorical variables were summarized using numbers with percentages. We assessed differences between the cardiac injury group and the non-cardiac injury group using independent group t test for continuous variables that were normally distributed, or Mann-Whitney U test for continuous variables that were not normally distributed; Chi-square test for the other categorical variables.

The Spearman correlation coefficient was calculated to disclose relationship of hs-cTnI with inflammatory cytokines. To explore the risk factors associated with cardiac injury, logistic 6 regression analysis was used. All statistical analyses were performed using SPSS software (Statistical Package for the Social Sciences) version 26.0 (SPSS Inc.). Statistical graphs were applied to GraphPad Prism 5 (GraphPad Software, La Jolla, CA). Tests were two-sided with statistical significance set at P value of less than 0.05. 7 

We included 330 cases, which were clinically diagnosed as severe and critically ill COVID-19.

The median age was 67 years, ranging from 42 to 92 years, and 48.8% (n = 161) of patients were men. We found that 32.4% (n = 107) of patients presented cardiac injury. Among all cardiovascular comorbidities, hypertension was the most common in (48.8%, n = 161) patients, followed by diabetes (16.7%, n = 55) and coronary heart disease (CHD) (13.3%, n = 44). The serum concentrations of hs-cTnI in patients with cardiac injury significantly increased compared with those without cardiac injury [51.4 (32.4-91.8) pg/mL vs 15.0 (9.5-20.8) pg/mL, P < 0.001; FIGURE 1 ]. In the further analyses, we found that the patients in the cardiac injury group were significantly older than those in the non-cardiac injury group. Meanwhile, there was significant difference in the proportions of CHD between the cardiac injury group and the non-cardiac injury group (TABLE 1) .

CT examination of the chest could provide great help in diagnosis of COVID-19 with typical images of chest. As shown in FIGURE 2, the most common CT manifestation was multiple mottling and ground-glass opacity along the outer bands of both lungs of a men aged 70 years with severe COVID-19.

Of 330 severe and critically ill cases with COVID-19 who underwent laboratory examination on admission, the patients had elevated leukocyte counts and concentrations of NT-proBNP, but decreased lymphocyte counts (TABLE 2) 

To investigate the relationship to hs-cTnI and inflammatory cytokines, we We excluded 8 variables from the univariable analyses if their between-group differences were not significant.

We discovered a significant positive correlation of hs-cTnI with hs-CRP (r = 0.170, P = 0.002), TNF-α (r = 0.145, P = 0.008), IL-2R (r = 0.115, P = 0.036), IL-6 (r = 0.238, P < 0.001), and IL-8 (r = 0.260, P < 0.001) (FIGURE 4) . But no correlation was observed between IL-10 and IL-1β.

Stepwise logistic regression analyses were employed to predict the risk factors for cardiac injury. In order to avoid overfitting in the model, we fitted logistic regression models with the variables with a P value of < 0.05 identified from the univariate analyses. In stepwise logistic regression analyses, cardiac injury was association with hs-CRP (OR 1.006, 95% CI 1.001-1.012, P = 0.014), TNF-α (OR 1.039, 95% CI 1.006-1.072, P = 0.020), IL-6 (OR 1.003, 95% CI 1.001-1.005, P = 0.042). 9 

and multi-organ damage due to the pathophysiology of a high inflammatory burden. 8, 9 To the best of our knowledge, inflammatory response is considered to help protect against infection and a self-limiting process as once the infection has been cleared by immune system. However, disruption or poor regulation of this normal pattern could lead to excessive release of inflammatory cytokines, resulting in hyper-inflammatory response known as a cytokine storm. 10 In this study including 330 inpatients with severe and critically ill COVID-19, we found that 32.4% of patients suffered from cardiac injury. Moreover, older cases were more susceptible to cardiac injury which was consistent with previous studies. 11 Similarly, concentrations of NT-proBNP were significantly elevated in the cardiac injury group, suggesting severity of inflammatory response and ventricular dysfunction. In the univariate analyses, our data showed that leukocyte and lymphocyte counts, the levels of hs-CRP, TNF-α, IL-2R, IL-6, and IL-8 were significantly different between patients with and without cardiac injury. Moreover, our study showed that the serum level of hs-cTnI positively correlated with increased inflammatory cytokines. Taken together, leukocyte counts, hs-CRP, inflammatory cytokines, particularly, pro-inflammatory cytokines including TNF-α, IL-2R, IL-6, IL-8, were common among severe and critically ill patients, and more evident in those with cardiac injury. Therefore, it is reasonable to hypothesize that the excess production of pro-inflammatory cytokines could result in a deficiency in control of viral replication and enhanced inflammatory responses. 9 Accumulating evidences suggested that hyper-inflammatory response, a cytokines storm syndrome, reflected by elevated leukocytes, hs-CRP, and pro-inflammatory cytokines, is an important contributor to cardiac injury and damage of other organs. 11 In the further analyses, we found that hs-CRP, TNF-α, and IL-6 were independent risk factors for cardiac injury in severe and critically ill patients with COVID-19 using stepwise logistic regression model. The findings were in consistent with previous reports that the patients had a heightened risk of developing cardiac injury with increased levels of inflammatory cytokines. 12 Based on these data, SARS-CoV-2 might aggravate inflammatory response and result in release of pro-inflammatory cytokines, which promoted the development of cardiac injury.

Up to this day, the pleiotropic properties of the pro-inflammatory cytokines and their 10 multifunctional effects involved in cardiac injury are not completely known in COVID-19.

thought to play a pivotal role in the pathogenesis of organ damage. 4, 5 Although there is no direct evidence for the involvement of inflammatory cytokines in the cardiac pathology during COVID-19, the change of inflammatory cytokines in infected patients were correlated with myocardial injury. With an increase in differential evidences, hyper-inflammatory response can lead to myocardial ischemia in the presence of preexisting cardiovascular comorbidities as pro-inflammatory cytokines are mediators of atherosclerosis directly contributing to destabilizing atherosclerotic plaques of coronary through excess inflammation. 13, 14 Inflammation also causes endothelial dysfunction and increases the procoagulant activity of the blood, which can contribute to induction of procoagulant factors and haemodynamic changes, and formation of an occlusive thrombus over a ruptured coronary artery plaque, which predispose to worsen microvascular pathophysiology. 15, 16 Based on these lines of evidences, we postulated that hyper-inflammatory response may precipitate cardiac injury observed in severe and critically ill patients with COVID-19.

In contrast, a previous study found that cardiac injury appeared to be common in acute SARS infection, even among those without underlying cardiovascular disease. 17 On the basis of recent studies, angiotensin-converting enzyme 2 (ACE2), the receptor with a strong binding affinity to the spike protein of SARS-CoV-2, is highly expressed on myocytes and vascular endothelial cells, thus there is at least theoretical potential possibility of direct cardiac involvement by the coronavirus. 18, 19 However, a recent study suggested that SARS-CoV-2 might damage myocardium through inflammation rather than not directly impair the heart, and the coronavirus in the acute phase might be attributable to the cytokine storm syndrome. 20 The hallmark of cytokine storm syndrome is an uncontrolled and dysfunctional inflammatory response involving the continuous activation and proliferation of lymphocytes and macrophages. Furthermore, the excess production of cytokines could lead to a deficiency in control of viral replication and more prolonged pro-inflammatory response, inducing endothelial cell adhesion molecule synthesis and activate leukocyte integrins, mediating strong adhesive interactions that ultimately lead to extravasation of inflammatory cells into the myocardium, potentially leading to myocardial damage. 21 11 Nonetheless, what seemed to emerge from our results was that pro-inflammatory cytokines significantly increased in cardiac injury among severe and critically ill patients, and positively correlated with hs-cTnI. It is hence reasonable to consider that initial measurement of inflammatory cytokines immediately after hospitalization for COVID-19 may help screen a subset of patients with possible cardiac injury and thereby predict the progression of COVID-19 towards a worse clinical picture.

Our study had some limitations. Owing to the retrospective, single-center, small sample study, not all inflammatory biomarkers were tested in all patients. Furthermore, this study was to identify broad systemic inflammation linked to cardiac injury. In addition, interpretation of our findings might be limited by lack of integrative functional immune data and relatively small sample size. Moreover, there were also several other clinical tools such as electrovardiogram, chocardiogram, which were unavailable, but could potentially better explain myocardial injury and warranted further research. Last but not least, due to the exploratory nature of the study, standardized data for a larger cohort would be better to identify cardiac injury. Additional research should also be planned to clarify the contributory mechanisms underlying the hyper-inflammatory response involves in cardiac injury among severe and critically ill patients with COVID-19. 12 

In summary, the data of our study explained novel information on the association between hyper-inflammatory response and myocardial damage, which indicated that hyper-inflammatory response may highly involve in cardiac injury. Although the exact mechanism of hyper-inflammatory response mediated-cardiac injury needs to be further investigated, the findings presented here are urgently needed to consider anti-inflammatory treatment and adjunctive cardioprotective therapies in COVID-19 management for reducing fatality related to high incidence of cardiac injury among severe and critically ill patients with COVID-19. 13 

GZ Xia designed the study, had full access to all of the data, took responsibility for the integrity of the data and the accuracy of the data analyses, drafted the manuscript. D Fan, CR Ma and YR He contributed to data confirmation and analyses, participated in drafting the manuscript.

M Wang and YH Zhu collected clinical data and laboratory values and CT images, obtained the ethical approval. QS Zheng has provided valuable guidance in every stage of the writing of this thesis.

We declare no competing interests. 

WHO-China Joint Mission. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19)

Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity

Pathogenic human coronavirus infections: causes and consequences of cytokines storm and immunopathology

Dysregulation of immune response in patients with COVID-19 in Wuhan, China

The fifth Revised Trial Version of the Novel Coronavirus Pneumonia Diagnosis and Treatment Guidance

Aberrant coagulation cause a hyper-inflammatory response in severe influenza pneumonia

Age-dependent dysregulation of innate immunity

Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19)

Potential effects of coronaviruses on the cardiovascular system: a review

Systemic infections cause exaggerated local inflammation in atherosclerotic coronary arteries: clues to the triggering effect of acute infections on acute coronary syndromes

Acute pneumonia and the cardiovascular system

Cardiovascular complications of acute respiratory infections: current research and future directions

Atherosclerotic plaque vulnerability in the stain era

Left ventricular performance in patients with severe acute respiratory syndrome: a 30-day echocardiographic follow-up study

Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

COVID-19 and the cardiovascular system

The immunopathogenesis of sepsis in elderly patients

Abbreviations: COVID-19, coronavirus disease

Continuous and categorical data were expressed as median with interquartile rang and numbers with percentages, respectively. Leukocyte counts

pg/mL 831

Abbreviations: COVID-19, coronavirus disease 2019; NT-proBNP, N-terminal pro-B-Type natriuretic peptide. Continuous and categorical data were expressed as median with interquartile rang and numbers with percentages

We thank all patients involved in the study.

The authors received no specific funding for this work. 14